Literature DB >> 33513993

Optimized Extraction of Amikacin from Murine Whole Blood.

Roccaldo Sardella1,2, Styliani Xiroudaki1, Laura Mercolini3, Samuele Sabbatini4, Claudia Monari4, Stefano Perito4, Federica Ianni1, Anna Vecchiarelli4, Stefano Giovagnoli1.   

Abstract

Amikacin (Amk) analysis and quantitation, for pharmacokinetics studies and other types of investigations, is conventionally performed after extraction from plasma. No report exists so far regarding drug extraction from whole blood (WB). This can represent an issue since quantification in plasma does not account for drug partitioning to the blood cell compartment, significantly underrating the drug fraction reaching the blood circulation. In the present work, the optimization of an extraction method of Amk from murine WB has been described. The extraction yield was measured by RP-HPLC-UV after derivatization with 1-fluoro-2,4-dinitrobenzene, which produced an appreciably stable derivative with a favorable UV/vis absorption. Several extraction conditions were tested: spiked Amk disulfate solution/acetonitrile/WB ratio; presence of organic acids and/or ammonium hydroxide and/or ammonium acetate in the extraction mixture; re-dissolution of the supernatant in water after a drying process under vacuum; treatment of the supernatant with a solution of inorganic salts. The use of 5% (by volume) of ammonium hydroxide in a hydro-organic solution with acetonitrile, allowed the almost quantitative (95%) extraction of the drug from WB.

Entities:  

Keywords:  pharmaco-toxicological investigation; sample derivatization; screening of extraction conditions

Mesh:

Substances:

Year:  2021        PMID: 33513993      PMCID: PMC7865403          DOI: 10.3390/molecules26030665

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  22 in total

1.  Comparative pharmacokinetics of amikacin and kanamycin.

Authors:  J T Clarke; R D Libke; C Regamey; W M Kirby
Journal:  Clin Pharmacol Ther       Date:  1974-06       Impact factor: 6.875

2.  Amikacin pharmacokinetics: wide interpatient variation in 98 patients.

Authors:  D E Zaske; R G Strate; P R Kohls
Journal:  J Clin Pharmacol       Date:  1991-02       Impact factor: 3.126

3.  Highly sensitive spectrofluorimetric method for determination of certain aminoglycosides in pharmaceutical formulations and human plasma.

Authors:  Mahmoud A Omar; Dalia M Nagy; Mohamed A Hammad; Alshymaa A Aly
Journal:  AAPS PharmSciTech       Date:  2013-04-26       Impact factor: 3.246

4.  Pharmacokinetics of Amikacin in Critical Care Patients on Extracorporeal Device.

Authors:  Jesus Ruiz-Ramos; Ricardo Gimeno; Francisca Pérez; Paula Ramirez; Esther Villarreal; Monica Gordon; Carlos Vicent; María Remedios Marqués; Álvaro Castellanos-Ortega
Journal:  ASAIO J       Date:  2018 Sep/Oct       Impact factor: 2.872

Review 5.  Optimizing aminoglycoside use.

Authors:  William A Craig
Journal:  Crit Care Clin       Date:  2011-01       Impact factor: 3.598

6.  Achiral-chiral two-dimensional chromatography of free amino acids in milk: A promising tool for detecting different levels of mastitis in cows.

Authors:  Federica Ianni; Roccaldo Sardella; Antonella Lisanti; Antimo Gioiello; Beniamino Terzo Cenci Goga; Wolfgang Lindner; Benedetto Natalini
Journal:  J Pharm Biomed Anal       Date:  2015-01-03       Impact factor: 3.935

7.  Fit-for-purpose chromatographic method for the determination of amikacin in human plasma for the dosage control of patients.

Authors:  C Ezquer-Garin; L Escuder-Gilabert; Y Martín-Biosca; R Ferriols Lisart; S Sagrado; M J Medina-Hernández
Journal:  Talanta       Date:  2015-12-21       Impact factor: 6.057

8.  Pulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in Rats.

Authors:  Vladimir Malinin; Mary Neville; Gina Eagle; Renu Gupta; Walter R Perkins
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

9.  Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen.

Authors:  Hideo Kato; Mao Hagihara; Jun Hirai; Daisuke Sakanashi; Hiroyuki Suematsu; Naoya Nishiyama; Yusuke Koizumi; Yuka Yamagishi; Katsuhiko Matsuura; Hiroshige Mikamo
Journal:  Drugs R D       Date:  2017-03

Review 10.  Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease.

Authors:  Matt Shirley
Journal:  Drugs       Date:  2019-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.